Ackman, Other Allergan Shareholders Submit Paperwork For Meeting

Thomson ReutersWilliam Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks to the audience about Herbalife company in New York

BOSTON (Reuters) - Hedge fund manager William Ackman said on Friday that a total of 35 shareholders who own 31 percent of Allergan Inc.' s stock have called on the Botox maker to call a special meeting.

Ackman, whose Pershing Square Capital Management owns nearly 10 percent of Allergan's stock, has been working with Valeant Pharmaceuticals to try and buy Allergan in a deal valued at $49 billion.

Allergan required shareholders owning 25 percent of its shares to submit paperwork. Pershing Square also sued the company in Delaware to compel it to call the meeting.